Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Tauriga Sciences Inc. (OTCQB:TAUG), a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology, today announced that it has entered into an investment banking agreement with Tokyo, Japan based investment banking firm Dragoon Capital, Inc.
Through this investment banking agreement, Dragoon has agreed on a best efforts basis to secure the Company a private placement equity capital financing from its extensive base of both Japanese institutional and accredited individual investors. The proceeds from this private placement, if and when complete, should enable the Company to expand its medicinal cannabis and complementary natural wellness businesses as well as provide Pilus Energy with capital as it advances its pilot test program with the Metropolitan Sewer District of Greater Cincinnati and the EPA T&E department (Environmental Protection Agency’s Testing & Evaluation department).
Dragoon Capital Inc. is an independent investment banking firm that specializes in advising and funding emerging growth companies in Japan and worldwide. The shares offered under this investment banking agreement will be offered solely to Japanese domiciled institutional and accredited individual investors. The Company is also exploring the possibility of expanding some of its product lines to the Japanese marketplace.
Tauriga’s CEO, Dr. Stella M.Sung commented, “The Company is pleased to sign this investment banking agreement with Dragoon Capital and is excited to enhance its presence and visibility in the Japanese investor community. The Company is actively seeking opportunities to increase revenue and expand into new markets, both domestically and internationally.”
Dragoon Capital Inc. CEO Shuichi Uda stated, “Our investment banking firm is delighted to represent Tauriga Sciences, Inc. to the Japanese investment community. After careful due diligence, it was clear that Tauriga has a highly qualified management team and significant business opportunities in compelling growth segments of the market. We look forward to watching Tauriga evolve with the benefit of additional growth capital.”
Tauriga Sciences, Inc. (TAUG) is a diversified life sciences company with interests in the natural wellness sector and in developing a proprietary synthetic biology platform technology. The mission of the Company is to acquire and build a diversified portfolio of life science assets that is capital efficient and has the potential to generate meaningful profitable revenues. The Company’s business model includes the acquisition of licenses, equity stakes, rights on both an exclusive and non-exclusive basis, and entire businesses.
